Tag: weight management
Browse all articles tagged with “weight management”.
7 articles
Semaglutide and the GLP-1 Revolution: What Researchers Need to Know
A comprehensive research overview of semaglutide, the GLP-1 receptor agonist that has reshaped metabolic health research with over 169 PubMed studies, $29.3B in revenue, and expanding clinical applications from weight management to cardiovascular outcomes.
Semaglutide vs Tirzepatide: GLP-1 Agonist Comparison
A comprehensive comparison of semaglutide and tirzepatide, the two leading GLP-1 receptor agonists. Examine clinical trial data, mechanisms, efficacy, side effects, cost, and FDA approval status.
Tirzepatide: The Dual GIP/GLP-1 Receptor Agonist Reshaping Metabolic Research
A comprehensive research overview of tirzepatide, the dual GIP/GLP-1 receptor agonist marketed as Mounjaro and Zepbound. Explore its mechanism, SURMOUNT and SURPASS trial data, $16.5B revenue trajectory, and how it compares to semaglutide.
What Is Semaglutide? A Research Overview
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most studied compounds for weight management and metabolic health.
What Is Tirzepatide? A Research Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist that represents a new class of incretin-based therapeutics for type 2 diabetes and obesity management.
Liraglutide: The First-Generation Daily GLP-1 That Paved the Way
A comprehensive overview of liraglutide (Saxenda/Victoza), the first-generation daily GLP-1 receptor agonist with 97% homology to human GLP-1 that established the foundation for the entire class of incretin-based metabolic therapies.
Cagrilintide: The Long-Acting Amylin Analog Behind CagriSema
A research overview of cagrilintide, Novo Nordisk's investigational long-acting amylin analog designed for weekly dosing and studied in combination with semaglutide as CagriSema for enhanced weight management.
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.